Logo

ValueOS

byAIQL
Full portfolio
Performance views
Entity
EndocrinologyPSMMC Riyadh
ActiveTier 1
340Attributed Lives
Contract
Period
Composite ScoreClick to drill in →
92
Exceeds Stretch
1 from Q3 2025(1.1%)
96th percentile · 48 providers
88Q1
90Q2
91Q3
92Q4
Provider Score
Contract Target
Clinical95PROMs90Experience88Process91Cost94Equity90
Measure Scorecard — 45 measures · D1 30% · D2 20% · D3 10% · D5 15% · D7 15% · D9 10%Click any row to drill in · Click Adj to see risk adjustment
DimIDMeasureRawAdj ↗TargetFloorStretchStatusTrendCompl.
D3D3-003Care Coordination64.0%66.0%70%55%80%
Below Target
82%
D5D5-00530-Day Follow-up72.0%74.0%75%60%90%
Below Target
90%
D4D4-007Never Events0.050.07<0<1<0
Below Target
83%
D1D1-001HbA1c Control74.0%78.0%65%50%80%
At Target
96%
D1D1-003BP Control79.0%82.0%70%55%85%
At Target
95%
D1D1-004Retinopathy Screen85.0%87.0%75%60%90%
At Target
93%
D1D1-005Depression Remission40.0%44.0%35%20%50%
At Target
81%
D2D2-001EQ-5D Improvement0.0700.0720.050.020.08
At Target
77%
D2D2-002PHQ-9 Reduction3.8 pts4.0 pts31.55
At Target
76%
D2D2-003PROMs Completeness78.0%78.0%70%50%85%
At Target
100%
D2D2-004Functional Status68.0%70.0%60%45%75%
At Target
75%
D3D3-001Overall Satisfaction82.0%84.0%80%65%90%
At Target
88%
D3D3-002Shared Decision-Making78.0%80.0%75%60%85%
At Target
85%
D5D5-001ADA Adherence84.0%86.0%75%60%90%
At Target
93%
D5D5-002APA Adherence78.0%80.0%70%55%85%
At Target
89%
D5D5-003Med Reconciliation91.0%92.0%85%70%95%
At Target
96%
D5D5-004Foot Exam Rate83.0%85.0%80%65%90%
At Target
94%
D7D7-001Total CostSAR 41,200SAR 39,800<SAR 45,000<SAR 55,000<SAR 38,000
At Target
99%
D7D7-002ED Utilization210195<250<350<180
At Target
98%
D7D7-003Readmission Rate9.2%8.5%<12%<18%<8%
At Target
98%
D7D7-004Generic Prescribing86.0%87.0%80%65%90%
At Target
100%
D9D9-001Outcome Equity0.0800.075<0.1<0.2<0.05
At Target
91%
D9D9-002Access Equity0.1200.115<0.15<0.25<0.08
At Target
89%
D9D9-003PROMs Equity0.0900.085<0.1<0.2<0.05
At Target
88%
D4D4-001HAI Rate1.871.8<2.5<4<1.5
At Target
83%
D4D4-002CAUTI0.660.71<1.2<2<0.6
At Target
89%
D4D4-005Med Error Rate0.630.7<1<2<0.5
At Target
94%
D4D4-008VTE Prophylaxis95.6%95.6%90%80%97%
At Target
78%
D6D6-001Enrollment91.3%92.0%85%70%95%
At Target
83%
D6D6-002Baseline Capture90.8%89.9%80%65%92%
At Target
89%
D6D6-005Med Adherence88.3%87.4%80%70%90%
At Target
94%
D6D6-006Attendance91.7%92.0%82%70%92%
At Target
84%
D6D6-007PROMs Completion78.4%77.9%65%50%80%
At Target
83%
D8D8-001TCOC PMPMSAR 2,974SAR 2,960<SAR 3,112<SAR 3,400<SAR 2,900
At Target
83%
D8D8-004Avoidable ED158.38158.9<180<220<150
At Target
76%
D8D8-005Avoidable Admits43.0144.57<55<75<40
At Target
94%
D8D8-007Generic Rx91.1%90.8%85%75%92%
At Target
83%
D8D8-00830-day Readmit8.8%8.8%<12%<18%<8%
At Target
78%
D10D10-004NPHIES/FHIR92.0191.82857095
At Target
76%
D10D10-006Data Quality95.7495.99887596
At Target
84%
D10D10-008Workforce89.73089.782806592
At Target
78%
D10D10-010PROMs Infra90.890.15826894
At Target
82%
D10D10-012CDS Adoption86.6%85.9%75%60%90%
At Target
81%
D1D1-002LDL Control72.0%75.0%60%45%75%
Exceeds Stretch
94%
D1D1-006Complication Rate5.2%4.8%<8%<15%<5%
Exceeds Stretch
97%
Alerts
PROMs completeness above target
D2-003 at 78% — 8pp above minimum. Maintain collection cadence for settlement.
INFO
D3-003 Care Coordination below target
Score 66% vs 70% target. 2nd consecutive period. Monitor for corrective action threshold.
INFO